#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Italy Spain

  • A study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany Greece Hungary Italy +5

  • Study of MTX-463 compared to placebo to assess its safety and effectiveness in adults with idiopathic pulmonary fibrosis

    Recruiting

    2 1 1
    Investigated Drugs:
    Belgium Croatia France Ireland The Netherlands Spain

  • Study of inhaled LTI-03 for safety and effectiveness in patients with Idiopathic Pulmonary Fibrosis who may be receiving standard antifibrotic therapy

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Poland

  • Study of BI 765423 given by intravenous infusion for patients with idiopathic pulmonary fibrosis with or without standard treatment

    Recruiting

    2 1
    Investigated Diseases:
    Belgium Germany Italy Spain

  • Long-Term Safety Study of Inhaled Pirfenidone for Patients with Progressive or Idiopathic Pulmonary Fibrosis

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Italy The Netherlands Poland +1

  • Study on the Effects of Methylprednisolone and Prednisone for Treating Acute Flare-Ups in Idiopathic Pulmonary Fibrosis Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Croatia Czechia Denmark Estonia +14

  • Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Denmark Finland France Germany +8

  • A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

    Not yet recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Italy +5